Literature DB >> 16678560

Functional gastroduodenal disorders.

Jan Tack1, Nicholas J Talley, Michael Camilleri, Gerald Holtmann, Pinjin Hu, Juan-R Malagelada, Vincenzo Stanghellini.   

Abstract

A numerically important group of patients with functional gastrointestinal disorders have chronic symptoms that can be attributed to the gastroduodenal region. Based on the consensus opinion of an international panel of clinical investigators who reviewed the available evidence, a classification of the functional gastroduodenal disorders is proposed. Four categories of functional gastroduodenal disorders are distinguished. The first category, functional dyspepsia, groups patients with symptoms thought to originate from the gastroduodenal region, specifically epigastric pain or burning, postprandial fullness, or early satiation. Based on recent evidence and clinical experience, a subgroup classification is proposed for postprandial distress syndrome (early satiation or postprandial fullness) and epigastric pain syndrome (pain or burning in the epigastrium). The second category, belching disorders, comprises aerophagia (troublesome repetitive belching with observed excessive air swallowing) and unspecified belching (no evidence of excessive air swallowing). The third category, nausea and vomiting disorders, comprises chronic idiopathic nausea (frequent bothersome nausea without vomiting), functional vomiting (recurrent vomiting in the absence of self-induced vomiting, or underlying eating disorders, metabolic disorders, drug intake, or psychiatric or central nervous system disorders), and cyclic vomiting syndrome (stereotypical episodes of vomiting with vomiting-free intervals). The rumination syndrome is a fourth category of functional gastroduodenal disorder characterized by effortless regurgitation of recently ingested food into the mouth followed by rechewing and reswallowing or expulsion. The proposed classification requires further research and careful validation but the criteria should be of value for clinical practice; for epidemiological, pathophysiological, and clinical management studies; and for drug development.

Entities:  

Mesh:

Year:  2006        PMID: 16678560     DOI: 10.1053/j.gastro.2005.11.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  497 in total

1.  Fatigue: a prevalent symptom in gastroparesis.

Authors:  Dinu Cherian; Susmita Paladugu; Murali Pathikonda; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2012-06-05       Impact factor: 3.199

2.  Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?

Authors:  Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

3.  A case of cyclic vomiting syndrome responding to gonadotropin-releasing hormone analogue.

Authors:  Young Kook Shin; Joong Goo Kwon; Ka Young Kim; Jae Bum Park; Seok Jae Han; Jong Woon Cheon; Eun Young Kim; Ho Gak Kim; Tae Sung Lee; Kyung Sik Park; Kyoung Sook Won
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

4.  Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.

Authors:  Andrew K Roorda; Samuel N Marcus; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-04-22       Impact factor: 3.199

5.  Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control.

Authors:  Stefano Ginanni Corradini; Flaminia Ferri; Michela Mordenti; Luigi Iuliano; Maria Siciliano; Maria Antonella Burza; Bruno Sordi; Barbara Caciotti; Maria Pacini; Edoardo Poli; Adriano De Santis; Aldo Roda; Carolina Colliva; Patrizia Simoni; Adolfo Francesco Attili
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

6.  Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males.

Authors:  R S Choung; G R Locke; R M Lee; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2011-09-27       Impact factor: 3.598

7.  Functional Dyspepsia: A New Rome III Paradigm.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

Review 8.  Current management strategies and emerging treatments for functional dyspepsia.

Authors:  Michael Camilleri; Vincenzo Stanghellini
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-05       Impact factor: 46.802

9.  Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms.

Authors:  A Desai; M O'Connor; B Neja; K Delaney; M Camilleri; A R Zinsmeister; A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2018-05-02       Impact factor: 3.598

10.  Itopride therapy for functional dyspepsia: a meta-analysis.

Authors:  Xuan Huang; Bin Lv; Shuo Zhang; Yi-Hong Fan; Li-Na Meng
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.